Report - Nov 02, 2018 CSPC Pharmaceutical Group [1093.HK] · We expect CSPC’s Clopidogrel to gain market share from Salubaris’s (002294.SZ) Taijia and Sanofi’s Plavix because of CSPC’s

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form